Specifically, HER2 tumors exhibit a higher concentration of CARM1 protein in the nucleus, while triple-negative breast cancer (TNBC) and HER2 tumors are associated with cytoplasmic expression of CARM1ΔE15 proteins [9, 10]. The gene discussed is ERBB2; the disease is triple-negative breast carcinoma.